Literature DB >> 28716165

Frontal Assessment Battery in Parkinson's Disease: Validity and Morphological Correlates.

Ondrej Bezdicek1, Filip Růžička1, Adela Fendrych Mazancova1, Jan Roth1, Pavel Dušek1, Karsten Mueller2, Evžen Růžička1, Robert Jech1.   

Abstract

OBJECTIVES: Executive dysfunction is a common feature in Parkinson's disease (PD). However, there is a lack of brief validated instruments for executive dysfunction in PD.
METHODS: The aim of the present study was to assess the relation of Frontal Assessment Battery (FAB) scores to age and education, to verify the utility of FAB in the evaluation of executive dysfunction in PD and to differentiate between controls (n=41), PD patients with normal cognition (PD-NC; n=41; Hoehn and Yahr stages 2-3) and PD with mild cognitive impairment (PD-MCI; n=32; Hoehn and Yahr stages 2-3). In addition, we studied the relation between voxel-based morphometric (VBM) data and FAB results in PD.
RESULTS: We found that FAB scores are significantly related to age and education. The FAB has shown discriminative validity for the differentiation of PD-MCI from PD-NC and controls (area under the curve >.80). Also, the VBM analysis revealed lower FAB scores are specifically related to lower gray matter density in the right ventromedial prefrontal areas and precuneus.
CONCLUSIONS: The FAB can be recommended as a valid instrument for PD-MCI Level I screening. FAB is sensitive to frontal lobe involvement in PD as reflected by lower gray matter density in prefrontal areas. (JINS, 2017, 23, 675-684).

Entities:  

Keywords:  Executive functions; FAB; Mild cognitive impairment; Parkinson’s disease; SPM; VBM

Mesh:

Year:  2017        PMID: 28716165     DOI: 10.1017/S1355617717000522

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  5 in total

1.  The Frontal Assessment Battery 20 years later: normative data for a shortened version (FAB15).

Authors:  Ciro Rosario Ilardi; Sergio Chieffi; Chiara Scuotto; Nadia Gamboz; Filomena Galeone; Maria Sannino; Elisabetta Garofalo; Marco La Marra; Bruno Ronga; Alessandro Iavarone
Journal:  Neurol Sci       Date:  2021-08-19       Impact factor: 3.307

2.  The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.

Authors:  Zeynep Idil Seckin; Joseph R Duffy; Edythe A Strand; Heather M Clark; Rene L Utianski; Mary M Machulda; Hugo Botha; Farwa Ali; Nha Trang Thu Pham; Val J Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2020-10-07       Impact factor: 4.891

3.  Spatial disorientation and executive dysfunction in elderly nondemented patients with Parkinson's disease.

Authors:  Davide M Cammisuli; Simon Crowe
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-02       Impact factor: 2.570

4.  Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test.

Authors:  Paola Ortelli; Davide Ferrazzoli; Viviana Versace; Veronica Cian; Marianna Zarucchi; Anna Gusmeroli; Margherita Canesi; Giuseppe Frazzitta; Daniele Volpe; Lucia Ricciardi; Raffaele Nardone; Ingrid Ruffini; Leopold Saltuari; Luca Sebastianelli; Daniele Baranzini; Roberto Maestri
Journal:  NPJ Parkinsons Dis       Date:  2022-04-11

5.  Comparison of Design Fluency Test Results among Patients with Parkinson's Disease, Frontotemporal Dementia, and the Control Group.

Authors:  Majid Barekatain; Fatemeh Rajabi; Amrollah Ebrahimi; Mohammad Reza Maracy; Sahar Akbaripour
Journal:  Adv Biomed Res       Date:  2021-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.